Elevation Spine
Elevation Spine is a Monterey, CA-based medical device company developing integrated-fixation spinal implant technologies, including the Saber-C zero-profile anterior cervical fusion system with proprietary in-line spike fixation.
- CEO / Founder
- Charles Gilbride
- Team Size
- 11-50
- Stage
- Growth Stage
- Total Funding
- $11M
- Latest Round
- Series B
- Key Investors
- Technology Venture Partners (TVP); Mutual Capital Partners (MCP)
Technology & Products
Key Products
Saber-C (zero-profile anterior cervical fusion system with spike and screw fixation); Saber-C AVIA (porous 3D-printed titanium interbody with 55% porosity lattice architecture, spike and screw fixation options)
Technological Advantage
Proprietary Saber in-line spike fixation technology enabling single-step simultaneous deployment at both endplates; zero-profile construct; 3D-printed porous titanium interbody (55% porosity lattice mimicking trabecular bone); seven total points of fixation; ability to access hard-to-reach cervical spine levels
Differentiation
Value Proposition
Proprietary Saber in-line spike fixation technology enables single-step simultaneous deployment at both endplates, reducing procedural complexity, surgical steps, incision size, and anesthesia time compared to traditional screw-based spinal implants.
How They Differentiate
Unlike traditional screw-based standalone spacers (a commoditized $500M sub-segment), Elevation Spine's Saber-C uses in-line spike fixation that eliminates the need for screw angulation, reduces instrument passages from 4-5 to 1, and allows access to hard-to-reach areas of the cervical spine. The system is one of the few zero-profile ACDF systems cleared as an anterior cervical plate rather than just a standalone interbody.
Market & Competition
Target Customers
Spine surgeons (orthopedic and neurosurgeons) performing anterior cervical discectomy and fusion (ACDF) procedures; hospitals and ambulatory surgery centers
Industry Verticals
Spine surgery; Medical devices; Orthopedics
Competitors
FloSpine; Retropsoas Technologies; Titan Spine
Growth & Milestones
Growth Metrics
Surpassed 5,000 Saber-C implantations as of June 2026; 21 employees as of May 2026; expanded from single-level to 2-level cervical fusion clearance
Major Milestones
2015: Company founded; 2021: Recognized as Top 10 Spine Device Company by MedTech Outlook; 2022: Closed $11M Series B financing led by Technology Venture Partners; 2025: FDA 510(k) clearance for 2-level cervical fusion indication; 2026 (June): Surpassed 5,000 Saber-C implantations; 2026 (July): FDA 510(k) clearance for Saber-C AVIA with porous 3D-printed titanium interbody
Notable Customers
Dr. Samuel Joseph (Orthopedic Spine Surgeon, Tampa, FL); Dr. Tien Le (Total Spine & Brain Institute)